Severe Systemic Fungal Infections
A systemic fungal infection invades the bloodstream or an internal organ. It differs from superficial thrush or ringworm and can become life-threatening, particularly with major immune or hospital-related risk factors.
Key takeaways
- Persistent fever, lung deterioration, neurological change or unexplained organ dysfunction may raise suspicion in a high-risk patient.
- Immune status, exposures, imaging, cultures and fungal antigen or molecular tests help identify species and affected sites.
- Antifungals differ in spectrum, tissue penetration, toxicity and interactions; treatment often begins in hospital before every result is known.
Catalogue matches are not treatment for suspected systemic fungal disease and must not delay specialist assessment.
Who is at increased risk?
Neutropenia, transplant treatment, advanced immune suppression, intensive-care illness, central lines and major abdominal surgery increase risk. Diabetes can raise susceptibility to some invasive fungi, especially when metabolic control is severely disrupted.
Why is species identification important?
Yeasts, moulds and endemic fungi do not respond to the same medicines. Organ function, resistance and interactions determine therapy. Oral ketoconazole is not routine treatment for systemic fungal infection because specialists generally choose safer or more suitable agents from antifungals.
When to seek urgent care
Seek emergency care for severe breathlessness, coughing blood, confusion, seizure, new weakness, rapidly dying tissue, or persistent fever with deterioration in an immunocompromised person.